Current role and future perspectives of radioiodinated MIBG in the evaluation of dementia with Lewy bodies.
Détails
ID Serval
serval:BIB_56284DFFC987
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Current role and future perspectives of radioiodinated MIBG in the evaluation of dementia with Lewy bodies.
Périodique
Current radiopharmaceuticals
ISSN
1874-4729 (Electronic)
ISSN-L
1874-4710
Statut éditorial
Publié
Date de publication
2014
Peer-reviewed
Oui
Volume
7
Numéro
1
Pages
75-78
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
Dementia with Lewy bodies (DLB) is the second most common cause of degenerative dementia after Alzheimer's disease (AD). To improve the diagnosis of DLB, the latest diagnostic criteria incorporate findings from neuroimaging studies including sympathetic innervation imaging with iodine-123-metaiodobenzylguanidine (MIBG). According to these criteria a decreased MIBG myocardial uptake is an important finding supporting a clinical diagnosis of DLB. In this review the state of art and future perspectives of sympathetic innervation imaging by using MIBG in the diagnosis of DLB are discussed.
Mots-clé
3-Iodobenzylguanidine, Biological Transport, Dementia/diagnosis, Dementia/diagnostic imaging, Diagnosis, Differential, Dopamine/chemistry, Humans, Iodine Radioisotopes, Lewy Body Disease/diagnosis, Lewy Body Disease/diagnostic imaging, Radionuclide Imaging, Radiopharmaceuticals, Tomography, Emission-Computed, Single-Photon
Pubmed
Création de la notice
20/08/2017 19:34
Dernière modification de la notice
20/08/2019 15:10
Données d'usage
